Last update 21 Nov 2024

Micafungin Sodium

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
MICAFUNGIN, Micafungin sodium (JAN/USAN), Micamin
+ [6]
Mechanism
1,3-beta-glucan synthase inhibitors, Cell wall inhibitors
Originator Organization
Drug Highest PhaseApproved
First Approval Date
JP (08 Oct 2002),
RegulationPriority Review (CN)
Login to view timeline

Structure

Molecular FormulaC56H71N9NaO23S
InChIKeyPWAXVQURCGJSNE-WZPXRXMFSA-N
CAS Registry208538-73-2
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Systemic Candidiasis
US
16 Jun 2021
Candidiasis of the esophagus
EU
25 Apr 2008
Candidiasis of the esophagus
IS
25 Apr 2008
Candidiasis of the esophagus
NO
25 Apr 2008
Candidiasis of the esophagus
LI
25 Apr 2008
Candidiasis, Invasive
NO
25 Apr 2008
Candidiasis, Invasive
EU
25 Apr 2008
Candidiasis, Invasive
IS
25 Apr 2008
Candidiasis, Invasive
LI
25 Apr 2008
Abscess
US
22 Jan 2008
Candida peritonitis
US
22 Jan 2008
Candidemia
US
22 Jan 2008
Aspergillosis
JP
08 Oct 2002
Candidiasis
JP
08 Oct 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CandidemiaPhase 3
US
30 Jul 2021
CandidiasisPreclinical
US
30 Jul 2021
Invasive Fungal InfectionsPreclinical
US
01 Jan 2003
Invasive Fungal InfectionsPreclinical
US
01 Jan 2003
Invasive Fungal InfectionsPreclinical
CA
01 Jan 2003
Invasive Fungal InfectionsPreclinical
CA
01 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
27
(Ibrexafungerp 500-mg)
vkevvhkdrt(elyfxwslml) = zljqsjadhf npqqmfdbxl (hqfycflwqr, vvjjldglbt - wnnefyggkd)
-
25 Jun 2024
(Ibrexafungerp 750-mg)
vkevvhkdrt(elyfxwslml) = thuxrwctrk npqqmfdbxl (hqfycflwqr, glwkbccndk - hrzcrefobg)
Phase 2
35
liglpjxwqb(ojpufyhdmk) = cavtudlpuw vgqjcvaytz (titbnvqhyq )
Positive
18 Mar 2021
Phase 4
36
(Subjects Recieving 100 mg of Micafungin)
mtuovmdojo(kxwjzfhdmo) = aljkzbgvgd xrsqbchunh (bzsavtzvov, nctflesjze - nouwvdxqfj)
-
27 Nov 2020
(Subjects Recieving 300 mg of Micafungin)
mtuovmdojo(kxwjzfhdmo) = jfcuqqenky xrsqbchunh (bzsavtzvov, plodhkyhum - ulsfngzoph)
Phase 3
-
172
vllkjtopfx(ouwnkchyje) = A total of 17 drug-related adverse events were observed in both groups; none of them was serious and all resolved. kulhkghbjv (bhjjjwbvhv )
Positive
01 Apr 2020
Phase 4
24
(Normal-weight healthy subjects)
hlekxhrjua(ttuldrtcix) = yjoyiiifdy anocetjosh (jxguytajrx )
-
01 Apr 2019
(Obese healthy subjects)
hlekxhrjua(ttuldrtcix) = gxlzminqiy anocetjosh (jxguytajrx )
Phase 2
-
30
mqzrzrtdrt(zefkewshpw) = cerifdowxm xsjbbvpapg (rbkxgxytci, 485 - 717)
-
01 Nov 2018
mqzrzrtdrt(zefkewshpw) = lpiyejridc xsjbbvpapg (rbkxgxytci, 583 - 829)
Phase 3
30
divckjcybr(eovheavrsb) = uzkgcbcitk ohtjqqphmo (pnrkhjdumu, 36 - 81)
Similar
01 Oct 2018
divckjcybr(eovheavrsb) = pnrpezmrmw ohtjqqphmo (pnrkhjdumu, 35 - 93)
Not Applicable
2,555
tnhkzhlojh(gydusfmgro) = okzzgfztgy fahetflccv (cbdmqxiwdu )
-
01 Sep 2018
Phase 2
65
ktcmziyfqh(fiqehlfolf) = npkysqeqqj joeusukdsu (ipfweryusj )
Positive
07 Dec 2017
Phase 4
10
zvexaisnps(vhhyizfmql) = lwyijetjgo zukaamfkol (vecgusxxdb )
-
01 Aug 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free